It is the first GLP-1 receptor agonist tablet licensed for weight management in the UK, giving you a needle-free alternative to the weekly Wegovy injection
Patients with genetic markers for faster GLP-1 receptor adaptation may benefit from earlier combination therapy (such as PlexusDx GLP-Squared, which combines semaglutide and tirzepatide) or periodic medication cycling to prevent plateau
[] GLP-1 RAs also play a role in central appetite regulation, leading to reduced food intake, and have direct cardioprotective and renoprotective effects, making them beneficial for both CV and renal health in patients with T2D
Understanding the full picture helps you make an informed decision
[DOI] [PubMed] [Google Scholar] 126.Casey R., Adelfio A., Connolly M., Wall A., Holyer I., Khaldi N